Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | -5.48% | -3.47% | -27.74% |
May. 23 | Lake Street Starts Myomo With Buy Rating, $7 Price Target | MT |
May. 08 | Transcript : Myomo, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.74% | 110M | - | ||
-7.38% | 181B | C+ | ||
-0.46% | 108B | C | ||
-6.98% | 66.12B | A | ||
+2.65% | 50.65B | B- | ||
+5.27% | 43.11B | B- | ||
+3.49% | 40.74B | B+ | ||
+19.92% | 31.6B | B | ||
+16.38% | 25.56B | A- | ||
-7.00% | 24.16B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MYO Stock
- Ratings Myomo, Inc.